Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gilbertson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|April 24, 2003
Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKMChristopher Calabrese, Adrian Frank, Kirsteen Maclean, et al.
International Journal of Cancer|October 17, 2008
Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genesJoon Won Yoon, Richard Gilbertson, Stephen Iannaccone, et al.
Glia|March 2, 2012
The brain tumor microenvironmentNikki A Charles, Eric C Holland, Richard Gilbertson, et al.
Glia|March 30, 2011
The brain tumor microenvironmentNikki A Charles, Eric C Holland, Richard Gilbertson, et al.
Science (New York, N.Y.)|November 27, 2010
Siah regulation of Pard3A controls neuronal cell adhesion during germinal zone exitJakub K Famulski, Niraj Trivedi, Danielle Howell, et al.
Neuro-Oncology Practice|May 14, 2026
Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024)Kathreena M Kurian, Andrew P Wright, Fereshteh Sari, et al.
Neuro-Oncology|November 29, 2014
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium studyLindsay B Kilburn, Mehmet Kocak, Rodney L Decker, et al.
Cancer Research|October 20, 2004
Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in miceClinton F Stewart, Markos Leggas, John D Schuetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 StudyRoger E Taylor, Clifford C Bailey, Kath Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|April 24, 2003
Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKMChristopher Calabrese, Adrian Frank, Kirsteen Maclean, et al.
International Journal of Cancer|October 17, 2008
Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genesJoon Won Yoon, Richard Gilbertson, Stephen Iannaccone, et al.
Glia|March 2, 2012
The brain tumor microenvironmentNikki A Charles, Eric C Holland, Richard Gilbertson, et al.
Glia|March 30, 2011
The brain tumor microenvironmentNikki A Charles, Eric C Holland, Richard Gilbertson, et al.
Science (New York, N.Y.)|November 27, 2010
Siah regulation of Pard3A controls neuronal cell adhesion during germinal zone exitJakub K Famulski, Niraj Trivedi, Danielle Howell, et al.
Neuro-Oncology Practice|May 14, 2026
Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024)Kathreena M Kurian, Andrew P Wright, Fereshteh Sari, et al.
Neuro-Oncology|November 29, 2014
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium studyLindsay B Kilburn, Mehmet Kocak, Rodney L Decker, et al.
Cancer Research|October 20, 2004
Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in miceClinton F Stewart, Markos Leggas, John D Schuetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 StudyRoger E Taylor, Clifford C Bailey, Kath Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastomaRoger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Pageof 2